Literature DB >> 20599306

Predictors of incident albuminuria in the Framingham Offspring cohort.

Conall M O'Seaghdha1, Shih-Jen Hwang, Ashish Upadhyay, James B Meigs, Caroline S Fox.   

Abstract

BACKGROUND: Predictors for incident albuminuria are not well known in population-based cohorts. The purpose of this study is to identify predictors of incident albuminuria in an unselected middle-aged population. STUDY
DESIGN: Observational cohort study. SETTING & PARTICIPANTS: Framingham Offspring Study participants who attended both the sixth (baseline; 1995-1998) and eighth (2005-2008) examination cycles. PREDICTORS: Standard clinical predictors were used. Predictors of incident albuminuria were identified using stepwise logistic regression analysis with age and sex forced into the model. OUTCOMES & MEASUREMENTS: Albuminuria was defined as urine albumin-creatinine ratio (UACR) ≥ 17 mg/g (men) or ≥ 25 mg/g (women). Individuals with albuminuria at baseline were excluded.
RESULTS: 1,916 participants were available for analysis (mean age, 56 years; 54% women). Albuminuria developed in 10.0% of participants (n = 192) during 9.5 years. Age (OR, 2.09; P < 0.001), baseline diabetes (OR, 1.93; P = 0.01), smoking (OR, 2.09; P < 0.001), and baseline log UACR (OR per 1-SD increase in log UACR, 1.56; P < 0.001) were associated with incident albuminuria in a stepwise model. An inverse relationship with female sex (OR, 0.53; P < 0.001) and high-density lipoprotein (HDL) cholesterol level (OR, 0.80; P = 0.007) also was observed. Results were similar when participants with baseline chronic kidney disease (n = 102), defined as estimated glomerular filtration rate <60 mL/min/1.73 m(2), were excluded from the model. Age, male sex, low HDL cholesterol level, smoking, and log UACR continued to be associated with incident albuminuria when baseline diabetes (n = 107) was excluded. Age, male sex, and log UACR correlated with incident albuminuria after participants with baseline hypertension were excluded (n = 651). LIMITATIONS: Causality may not be inferred because of the observational nature of the study. One-third of participants did not return for follow-up, potentially attenuating the observed risks of albuminuria.
CONCLUSIONS: The known cardiovascular risk factors of increasing age, male sex, diabetes, smoking, low HDL cholesterol level, and albuminuria within the reference range are correlates of incident albuminuria in the general population. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20599306      PMCID: PMC3198053          DOI: 10.1053/j.ajkd.2010.04.013

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  54 in total

Review 1.  'Hypertension' and 'microalbuminuria': the bell tolls for thee.

Authors:  J P Forman; B M Brenner
Journal:  Kidney Int       Date:  2006-01       Impact factor: 10.612

2.  Low levels of urinary albumin excretion are associated with cardiovascular risk factors in the general population.

Authors:  W M Janssen; H Hillege; S J Pinto-Sietsma; A A Bak; D De Zeeuw; P E de Jong
Journal:  Clin Chem Lab Med       Date:  2000-11       Impact factor: 3.694

3.  Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes.

Authors:  Auke H Brantsma; Stephan J L Bakker; Hans L Hillege; Dick de Zeeuw; Paul E de Jong; Ronald T Gansevoort
Journal:  Diabetes Care       Date:  2005-10       Impact factor: 19.112

4.  Predictors of the development of microalbuminuria in patients with Type 1 diabetes mellitus: a seven-year prospective study. The Microalbuminuria Collaborative Study Group.

Authors: 
Journal:  Diabet Med       Date:  1999-11       Impact factor: 4.359

5.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

6.  Long-term impact of systolic blood pressure and glycemia on the development of microalbuminuria in essential hypertension.

Authors:  Jose Maria Pascual; Enrique Rodilla; Carmen Gonzalez; Santiago Pérez-Hoyos; Josep Redon
Journal:  Hypertension       Date:  2005-05-16       Impact factor: 10.190

7.  Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.

Authors:  Folkert W Asselbergs; Gilles F H Diercks; Hans L Hillege; Ad J van Boven; Wilbert M T Janssen; Adriaan A Voors; Dick de Zeeuw; Paul E de Jong; Dirk J van Veldhuisen; Wiek H van Gilst
Journal:  Circulation       Date:  2004-10-18       Impact factor: 29.690

8.  Smoking is related to albuminuria and abnormal renal function in nondiabetic persons.

Authors:  S J Pinto-Sietsma; J Mulder; W M Janssen; H L Hillege; D de Zeeuw; P E de Jong
Journal:  Ann Intern Med       Date:  2000-10-17       Impact factor: 25.391

Review 9.  The epidemiology of chronic kidney disease.

Authors:  Robert C Atkins
Journal:  Kidney Int Suppl       Date:  2005-04       Impact factor: 10.545

10.  Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study.

Authors:  M Cirillo; L Senigalliesi; M Laurenzi; R Alfieri; J Stamler; R Stamler; W Panarelli; N G De Santo
Journal:  Arch Intern Med       Date:  1998-09-28
View more
  30 in total

1.  Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: the FAVORIT trial.

Authors:  D E Weiner; M A Carpenter; A S Levey; A Ivanova; E H Cole; L Hunsicker; B L Kasiske; S J Kim; J W Kusek; A G Bostom
Journal:  Am J Transplant       Date:  2012-05-17       Impact factor: 8.086

2.  Albuminuria and hypertension: the chicken or the egg?

Authors:  Yasuyuki Nagasawa; Yukiko Hasuike; Masayoshi Nanami; Takahiro Kuragano; Takeshi Nakanishi
Journal:  Hypertens Res       Date:  2014-09-04       Impact factor: 3.872

3.  The association of a single-nucleotide polymorphism in CUBN and the risk of albuminuria and cardiovascular disease.

Authors:  Gearoid M McMahon; Conall M O'Seaghdha; Shih-Jen Hwang; James B Meigs; Caroline S Fox
Journal:  Nephrol Dial Transplant       Date:  2013-09-19       Impact factor: 5.992

4.  Albuminuria and racial disparities in the risk for ESRD.

Authors:  William M McClellan; David G Warnock; Suzanne Judd; Paul Muntner; Reshma Kewalramani; Mary Cushman; Leslie A McClure; Britt B Newsome; George Howard
Journal:  J Am Soc Nephrol       Date:  2011-08-25       Impact factor: 10.121

5.  Cigarette smoking, proteinuria, and renal function in middle-aged Japanese men from an occupational population.

Authors:  Yuka Noborisaka; Masao Ishizaki; Minori Nakata; Yuichi Yamada; Ryumon Honda; Hitoshi Yokoyama; Masaru Miyao; Masaji Tabata
Journal:  Environ Health Prev Med       Date:  2011-08-24       Impact factor: 3.674

6.  Urine arsenic and prevalent albuminuria: evidence from a population-based study.

Authors:  Laura Y Zheng; Jason G Umans; Maria Tellez-Plaza; Fawn Yeh; Kevin A Francesconi; Walter Goessler; Ellen K Silbergeld; Eliseo Guallar; Barbara V Howard; Virginia M Weaver; Ana Navas-Acien
Journal:  Am J Kidney Dis       Date:  2012-11-09       Impact factor: 8.860

7.  Diabetes with poor glycaemic control does not promote atherosclerosis in genetically modified hypercholesterolaemic minipigs.

Authors:  Rozh H Al-Mashhadi; Martin M Bjørklund; Martin B Mortensen; Christina Christoffersen; Torben Larsen; Erling Falk; Jacob F Bentzon
Journal:  Diabetologia       Date:  2015-05-31       Impact factor: 10.122

8.  Renal artery calcium, cardiovascular risk factors, and indexes of renal function.

Authors:  Daniel A Roseman; Shih-Jen Hwang; Emily S Manders; Christopher J O'Donnell; Ashish Upadhyay; Udo Hoffmann; Caroline S Fox
Journal:  Am J Cardiol       Date:  2013-10-04       Impact factor: 2.778

Review 9.  Treatment and impact of dyslipidemia in diabetic nephropathy.

Authors:  Tadashi Toyama; Miho Shimizu; Kengo Furuichi; Shuichi Kaneko; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2013-11-07       Impact factor: 2.801

10.  Biomarkers of cardiovascular stress and incident chronic kidney disease.

Authors:  Jennifer E Ho; Shih-Jen Hwang; Kai C Wollert; Martin G Larson; Susan Cheng; Tibor Kempf; Ramachandran S Vasan; James L Januzzi; Thomas J Wang; Caroline S Fox
Journal:  Clin Chem       Date:  2013-07-19       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.